SERES HEALTH, INC.

Profile

Company Names

SERES HEALTH, INC.

Addresses

161 FIRST STREET, SUITE 2C, CAMBRIDGE, MA 02139

161 FIRST STREET, SUITE 1A, CAMBRIDGE, MA 02142

Phone Numbers

617 945 9626

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$123,628,965.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2014-12-19 
$64,999,998.00 
$64,999,998.00 
$0.00 
Equity 
2
2014-11-24 
$47,999,977.00 
$47,999,977.00 
$0.00 
Equity 
1
2014-05-23 
$10,628,990.00 
$10,628,990.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NOUBAR 
 
AFEYAN 
DIRECTOR
BIND BIOSCIENCES INC   |  BG MEDICINE, INC.   |  LS9, INC.   |  SELVENTA, INC.   |  BIND BIOSCIENCES, INC   |  MODERNA LLC   |  SERES HEALTH, INC.   |  PRONUTRIA BIOSCIENCES, INC.   |  CODIAK BIOSCIENCES, INC.   |  MODERNA THERAPEUTICS, INC.   |  AXCELLA HEALTH INC.
JOHN 
 
AUNINS 
EXECUTIVE OFFICER
SERES HEALTH, INC.
GREG 
 
BEHAR 
DIRECTOR
SERES HEALTH, INC.   |  ACCERA INC
DAVID 
 
BERRY 
DIRECTOR
DROBNY GLOBAL FUND LP   |  STAT HEALTH SERVICES INC.   |  BLEND BIOSCIENCES, INC.   |  SERES HEALTH, INC.   |  AVEDRO INC   |  PRONUTRIA BIOSCIENCES, INC.   |  AXCELLA HEALTH INC.   |  MAXINE-S HEAVENLY   |  BIOLINQ INC   |  AVERIN HEALTH OPPORTUNITIES FUND I LP   |  AVERIN SPV I LLC   |  AVERIN SPV II LLC   |  COMMONS CLINIC INC.   |  CLOVER FAST FOOD, INC.
WERNER 
 
CAUTREELS 
DIRECTOR
SOLVAY SA /FI   |  SELECTA BIOSCIENCES INC   |  SERES HEALTH, INC.   |  THIRD POLE, INC.   |  TRAWS PHARMA, INC.
DAVID 
 
COOK 
EXECUTIVE OFFICER
PANTHERYX, INC.   |  BIOTIE THERAPIES CORP.   |  SERES HEALTH, INC.   |  ALTO REIT, LLC   |  DEGREESIGHT INC   |  MORGAN HILLS CAPITAL, LLC   |  MORGAN STANLEY NEXT LEVEL FUND, L.P.   |  SHAED, INC.
PETER 
BARTON 
HUTT 
DIRECTOR
BIND BIOSCIENCES INC   |  SELECTA BIOSCIENCES INC   |  BLEND BIOSCIENCES, INC.   |  Q HOLDINGS, INC.   |  BLEND THERAPEUTICS, INC.   |  BIND BIOSCIENCES, INC   |  LIVING PROOF INC   |  SERES HEALTH, INC.   |  FLEX PHARMA, INC.   |  PRONUTRIA BIOSCIENCES, INC.   |  SUNEVA MEDICAL INC.   |  AXCELLA HEALTH INC.   |  WHOLE BIOME INC.   |  RUBIUS THERAPEUTICS, INC.   |  CEREHEALTH CORP   |  ATELERIX LIFE SCIENCES INC.   |  COLABS INT-L, CORP.
RICHARD 
 
KENDER 
DIRECTOR
SERES HEALTH, INC.   |  LONGEVERON INC.
LORENCE 
 
KIM 
DIRECTOR
SERES HEALTH, INC.   |  MODERNA LLC   |  MODERNA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  ASCENTA CAPITAL SPV I, L.P.   |  ASCENTA CAPITAL PROJECT TURING SPV, L.P.   |  ODYSSEY THERAPEUTICS, INC.   |  ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.   |  ASCENTA CAPITAL FUND I, L.P.   |  ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.   |  ASCENTA CAPITAL PROJECT HENRI SPV, L.P.   |  TRIANA BIOMEDICINES, INC.
ROGER 
 
POMERANTZ 
EXECUTIVE OFFICER, DIRECTOR
SERES HEALTH, INC.   |  X-VAX TECHNOLOGY, INC.   |  RUBIUS THERAPEUTICS, INC.   |  COLLPLANT BIOTECHNOLOGIES LTD   |  VIRACTA THERAPEUTICS, INC.   |  VIRACTA SUBSIDIARY, INC.   |  VERIMMUNE, INC.
ROGER 
J. 
POMERANTZ 
EXECUTIVE OFFICER, DIRECTOR
SERES HEALTH, INC.   |  X-VAX TECHNOLOGY, INC.   |  INTEC PHARMA LTD.   |  INDAPTUS THERAPEUTICS, INC.
ERIC 
D. 
SHAFF 
EXECUTIVE OFFICER
SERES HEALTH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-01-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2014-12-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-24 
2014-06-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#